Bought
Maintained
Sold
Other funds holding LLY
INVST's LLY Position: Q2 2026 in Review
INVST increased its Eli Lilly (LLY) stake by 64% in Q2 2026, buying an estimated $3.45M and bringing the position to 8,643 shares worth $10.4M. The position accounts for 1.01% of the portfolio, ranked #26.
INVST first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- INVST held 8,643 shares of Eli Lilly worth $10.4M as of Q2 2026.
- INVST bought 3,381 Eli Lilly shares in Q2 2026, an estimated $3.45M.
- Eli Lilly made up 1.01% of INVST's portfolio in Q2 2026, its #26 holding.
- INVST first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.